Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatients

Roni Shiloh, Avi Valevski, Liron Bodinger, Sagit Misgav, Dov Aizenberg, Pnina Dorfman-Etrog, Abraham Weizman*, Hanan Munitz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatients'. Together they form a unique fingerprint.

Medicine & Life Sciences